Publications

5808 Results

Markers of folate metabolism in pancreatic cancer: thymidylate synthase, thymidine phosphorylase, and MTHFR. results from the RTOG 9704 prospective randomized adjuvant treatment trial

Authors
JJ Farrell;K Winter;M Van Rijnsoever;W Regine;R Abrams;H Safran;J Macdonald;AB Benson;C Willett;H Elsaleh
Journal / Conference
ASCO 2006 Gastrointestinal Cancers Symposium #144
Year
2006
Research Committee(s)
Gastrointestinal
Study Number(s)
R9704

Absolute PSA value after androgen deprivation (AD) is a strong independent predictor of survival in new metastatic (D2) prostate cancer (PCa): Data from Soutwest Oncology Group trial 9346 (INT-0162)

Authors
M Hussain;C Tangen;P Schellhammer;ED Crawford;C Higano;G Wilding;A Akdas;EJ Small;B Donnelly;D Raghavan
Journal / Conference
Proc of the ASCO, Journal of Clinical Oncology 24(18S):#4517
Year
2006
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9346

Association of erectile dysfunction and subsequent cardiovascular disease

Authors
IM Thompson Jr;J Probstfield;C Tangen;P Goodman;C Moinpour;CA Coltman Jr
Journal / Conference
Proc of the AUA, Journal of Urology 175(4) Suppl:429 (#1333)
Year
2006
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Prognostic value of hemoglobin change after initiation of androgen deprivations therapy for newly diagnosed metastatic prostate cancer: a multivariate analysis of SWOG 8894

Authors
TM Beer;BH Goldman;CM Tangen;LB Bland;M Hussain;TG DeLoughery;ED Crawford
Journal / Conference
Proc of the AUA, Journal of Urology 175(4) Suppl:385-386, (#1197)
Year
2006
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8894 (INT-0105) (EST-2889)

Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321

Authors
B Barlogie;RA Kyle;KC Anderson;PR Greipp;HM Lazarus;DD Hurd;J McCoy;DF Moore Jr;SR Dakhil;KS Lanier;RA Chapman;JN Cromer;SE Salmon;B Durie;JJ Crowley
Journal / Conference
Journal of Clinical Oncology 24(6):929-936
Year
2006
Research Committee(s)
Myeloma
Study Number(s)
SWOG-9321

Assessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial

Authors
IM Thompson;DP Ankerst;C Chi;PJ Goodman;CM Tangen;MS Lucia;Z Feng;HL Parnes;CA Coltman, Jr.
Journal / Conference
Journal of the National Cancer Institute 98(8):529-534
Year
2006
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Quality of life and pain in advanced stage prostate cancer: results of a Southwest Oncology Group randomized trial comparing docetaxel/estramustine to mitoxantrone/prednisone

Authors
DL Berry;CM Moinpour;CS Jiang;DP Ankerst;DP Petrylak;LV Vinson;PN Lara;S Jones;ME Taplin;PA Burch;MHA Hussain;ED Crawford
Journal / Conference
Journal of Clinical Oncology 24(18):2828-2835
Year
2006
Research Committee(s)
Genitourinary
Study Number(s)
S9916

Southwest Oncology Group phase II study of arsenic trioxide in patients with refractory germ cell malignancies

Authors
TM Beer;CM Tangen;CR Nichols;KA Margolin;R Dreicer;WT Stephenson;DI Quinn;D Raghavan;ED Crawford
Journal / Conference
Cancer 106(12):2624-2629
Year
2006
Research Committee(s)
Genitourinary
Study Number(s)
S0207

The prognostic value of hemoglobin change after initiating androgen-deprivation therapy for newly diagnosed metastatic prostate cancer: a multivariate analysis of Southwest Oncology Group study 8894

Authors
TM Beer;CM Tangen;L Bland;M Hussain;BH Goldman;TG DeLoughery;ED Crawford
Journal / Conference
Cancer 107(3):489-496
Year
2006
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8894 (INT-0105) (EST-2889)

Pretreatment CA-125 and risk of relapse in advanced ovarian cancer

Authors
M Markman;PY Liu;M Rothenberg;BJ Monk;M Brady;DS Alberts
Journal / Conference
Journal of Clinical Oncology 24(9):1454-1458
Year
2006
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9326, S9701